Board Meeting Details

  • Meeting Date: Thursday, August 13, 2026
  • Meeting Venue: Registered office of the company
  • Agenda Items:
  • To consider and approve the Unaudited Standalone Financial Results for the quarter ended June 30, 2026
  • To consider any other matter with the permission of the Chair

Trading Window Restrictions

Trading window for designated persons, designated employees, specified persons and their immediate relatives remained closed from July 1, 2026 until the expiry of 48 hours after the financial results are approved for the quarter ended June 30, 2026.

Financial Impact

Financial results for Q1 FY27 (quarter ended June 30, 2026) are pending board approval. Actual financial figures and impact will be disclosed after board meeting.